Discovery projects


Gut microbiome-based innovations are still in their infancy and hold vast potential. Our drug discovery projects target life-impacting diseases for which there are few or no existing treatments.

Microbiome-related R&D activities in the academic world are growing rapidly, especially in high-potential therapeutic fields (such as inflammatory diseases, cancer and neurodegenerative diseases).

Using our expertise and understanding of the microbiome, we are constantly looking for detecting new innovation and projects that have the potential to become innovative microbiome-based drug candidates.

We welcome understanding research teams working on the microbiome to engage with us.

Want to talk to our CSO?


LNC02 is a technical platform dedicated to developing expert know-how on Christensenella.

For this purpose, LNC is setting up a technical platform dedicated to studying the bacteria’s mechanisms of action, isolating new bacterial strains and targeting new therapeutic applications.

Microbiome & us
Jan 13, 2020
We are looking for Clinical Project Manager | WHAT WE OFFER An exciting opportunity to dive in and begin your career...
> more
Dec 11, 2019
LNC Therapeutics and the National Institute for Agricultural Research (INRA) sign research partnership to study anti-...
> more
Press / Media
Nov 12, 2019
Biotechs investments disrupt Big Pharma business model The pharmaceutical industry is in a state of flux, with...
> more
Sep 6, 2019
Chaque semaine, Maddyness dresse le bilan des levées de fonds de la semaine qui vient de s’écouler. Cette semaine,...
> more
Dec 6, 2019
The term “microbiome” refers to the collection of microorganisms (or microbiota) – including bacteria, viruses and...
> more
Oct 28, 2019
Jillian L. Waters, Ruth E. Ley The Christensenellaceae, a recently described family in the phylum Firmicutes, is emerging...
> more
now on twitter
LNC Therapeutics

Eating right for gut health – An interview with Natasha Haskey, Registered Dietitian. Via

LNC Therapeutics © 2020 - all rights reserved terms and conditions